hlg-20231107

0001840292-23-000040.txt : 20231107 0001840292-23-000040.hdr.sgml : 20231107 20231107171004 ACCESSION NUMBER: 0001840292-23-000040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231107 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231107 DATE AS OF CHANGE: 20231107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Heliogen, Inc. CENTRAL INDEX KEY: 0001840292 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRIC SERVICES [4911] IRS NUMBER: 854204953 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40209 FILM NUMBER: 231385018 BUSINESS ADDRESS: STREET 1: 130 W UNION ST. CITY: PASADENA STATE: CA ZIP: 91103 BUSINESS PHONE: 9709240446 MAIL ADDRESS: STREET 1: 130 W UNION ST. CITY: PASADENA STATE: CA ZIP: 91103 FORMER COMPANY: FORMER CONFORMED NAME: Athena Technology Acquisition Corp. DATE OF NAME CHANGE: 20210112 8-K 1 hlg-20231107.htm 8-K hlg-20231107

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 7, 2023

Heliogen, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-40209

85-4204953

(State or other jurisdiction of

incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

130 West Union Street

Pasadena, California 91103


(Address of Principal Executive Offices)

Registrant's telephone number, including area code: (626) 720-4530

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.0001 par value per share

HLGN

New York Stock Exchange

Warrants, each 35 warrants exercisable for one share of common stock at an exercise price of $402.50 per share

HLGN.W

New York Stock Exchange

Preferred Share Purchase Rights

N/A

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 7, 2023, Heliogen, Inc. (the “Company”) received a letter from the staff of New York Stock Exchange (“NYSE”) Regulation notifying the Company that it had determined to commence proceedings to delist the Company’s common stock (NYSE: HLGN) and the Company’s public warrants to purchase common stock (NYSE: HLGN.W) from the NYSE. Trading in these securities was immediately suspended. The NYSE Regulation reached its decision to delist these securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000. The Company intends to appeal the delisting determination.

The Company anticipates that its common stock and the public warrants identified above will be traded in the over-the-counter (“OTC”) market commencing on November 8, 2023.

The Company has applied to have the common stock quoted on the OTCQX, the highest market tier operated by the OTC Markets Group, Inc. The Company has also applied to have the public warrants quoted on the OTCQX, if eligible. The Company intends to continue to comply with public company Securities and Exchange Commission (“SEC”) regulations and other NYSE listing requirements, including filing quarterly financial statements, having independently audited financials, and maintaining an independent Board of Directors with corporate governance rules and oversight committees.

For risks and uncertainties resulting from the delisting, refer to “Risk Factors—We are currently not in compliance with the NYSE’s continued listing requirements relating to the minimum average closing price and our stock may be delisted if we do not timely cure the non-compliance” under Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 29, 2023.

Item 7.01 Regulation FD Disclosure.

On November 7, 2023, the Company issued a press release with respect to the NYSE’s decision to delist the Company’s securities. A copy of the Company’s press release is being furnished as Exhibit 99.1 to this Form 8-K. The exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Forward-Looking Statements

This report includes “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Statements that are not historical in nature, including the words “may,” “will,” “anticipate,” “intend,” “expect” and other similar expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements related to the anticipated move of the Company’s common stock and public warrants to the OTC and the timing thereof, the potential future quoting of these securities on the OTCQX, our decision to appeal and the success of any such appeal of the NYSE delisting decision, and the Company’s compliance with public company SEC regulations. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this report, including but not limited to: logistical issues associated with transferring the trading of the Company’s securities from the NYSE to the OTC; the Company’s ability to satisfy the criteria for having its securities trade on OTCQX; and there is no assurance that an active market will be maintained for the Company’s common stock or public warrants. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the “Risk Factors” section in Part I, Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2022, as supplemented in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, and other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-

looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.


Exhibit Number						Description
99.1						Press Release, dated November 7, 2023
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			Heliogen, Inc.

Dated:	November 7, 2023	By:	/s/ Sagar Kurada
			Sagar Kurada
			Chief Financial Officer

EX-99.1 2 ex991-nysedelistingpressre.htm EX-99.1 Document

Exhibit 99.1

Heliogen Announces Suspension of NYSE Listing Status

Company’s Common Stock and Public Warrants Expected to Begin Trading Promptly on OTC Marketplace

PASADENA, Calif., November 7, 2023 – Heliogen, Inc. (“Heliogen” or the “Company”) (NYSE: HLGN), a leading provider of AI-enabled concentrating solar energy technology, today announced it has received notice that the New York Stock Exchange (“NYSE”) has determined to suspend trading of – and commence proceedings to delist – shares of Heliogen’s common stock and public warrants, effective immediately. This suspension was made because the Company fell below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15 million. The Company intends to appeal the delisting determination.

Heliogen anticipates that its common stock and public warrants will begin trading in the over-the-counter (“OTC”) marketplace on November 8, 2023 under the symbols HLGN and HLGNW, respectively. Investors are expected to continue to be able to access accurate information, including stock price quotes, and execute trades. The Company has applied to have its common stock – and potentially its public warrants, if eligible – quoted on the OTCQX, the highest market tier operated by the OTC Markets Group, Inc. For quotes or additional information on the OTC, investors may visit otcmarkets.com.

The change in Heliogen’s listing status does not impact the Company’s commitment to achieving its strategic priorities, including expanding its commercial reach and building out its sales pipeline. The Company continues to experience progress toward its goals and will continue to work to enhance value for all stakeholders.

“We remain highly confident in the global market opportunity for our proprietary technology and our ability to execute our strategic growth plan,” said Christie Obiaya, Chief Executive Officer of Heliogen. “Our cash position and commercial pipeline are strong, and we are well positioned to deploy our breakthrough renewable energy technology. We look forward to demonstrating the successful execution of our growth strategy in the months ahead.”

Heliogen intends to continue to comply with public company Securities Exchange Commission (“SEC”) regulations and other NYSE listing requirements, including filing quarterly financial statements, having independently audited financials, and maintaining an independent Board of Directors with corporate governance rules and oversight committees.

Additional information related to this announcement will be included in a Current Report on Form 8-K to be filed with the SEC.

About Heliogen

Heliogen is a renewable energy technology company focused on decarbonizing industry and empowering a sustainable civilization. The company’s concentrating solar energy and thermal storage systems aim to deliver carbon-free heat, steam, power, or green hydrogen at scale to support round-the-clock industrial operations. Powered by AI, computer vision and robotics, Heliogen is focused on providing robust clean energy solutions that accelerate the transition to renewable energy, without compromising reliability, availability, or cost. For more information about Heliogen, please visit heliogen.com.

Forward-Looking Statements

This press release includes “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Statements that are not historical in nature, including the words “may,” “will,” “anticipate,” “intend,” “expect” and other similar expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements related to the

Company’s business strategy and plans, the anticipated move of the Company’s common stock and public warrants to the OTC and the timing thereof, the potential future quoting of these securities on the OTCQX, our decision to appeal and the success of any appeal of the NYSE delisting decision, and the Company’s compliance with public company SEC regulations. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: logistical issues associated with transferring the trading of the Company’s securities from the NYSE to the OTC; the Company’s ability to satisfy the criteria for having its securities trade on OTCQX; and there is no assurance that an active market will be maintained for the Company’s common stock or public warrants. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the “Risk Factors” section in Part I, Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2022, as supplemented in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, and other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Heliogen Investor Contact:

Louis Baltimore

VP, Strategic Finance & Investor Relations

Louis.Baltimore@heliogen.com

Heliogen Media Contact:

Sam Padreddii

Manager, Corporate Communications

media@heliogen.com

Longacre Square Partners

Joe Germani / Miller Winston

heliogen@longacresquare.com

EX-101.SCH 3 hlg-20231107.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 hlg-20231107_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 hlg-20231107_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Preferred Share Purchase Right Preferred Share Purchase Right [Member] Preferred Share Purchase Right Document Period End Date Document Period End Date Common Stock Common Stock [Member] Pre-commencement Tender Offer Pre-commencement Tender Offer Class of Stock [Domain] Class of Stock [Domain] Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town Written Communications Written Communications Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Document Information [Line Items] Document Information [Line Items] Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code No Trading Symbol Flag No Trading Symbol Flag Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Warrant Warrant [Member] Document Type Document Type Amendment Flag Amendment Flag Entity Ex Transition Period Entity Ex Transition Period Class of Stock [Axis] Class of Stock [Axis] Document Information [Table] Document Information [Table] Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 6 hlg-20231107_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Nov. 07, 2023
Document Information [Line Items]
Document Type	8-K
Document Period End Date	Nov. 07, 2023
Entity Registrant Name	Heliogen, Inc.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-40209
Entity Tax Identification Number	85-4204953
Entity Address, Address Line One	130 West Union Street
Entity Address, City or Town	Pasadena
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91103
City Area Code	626
Local Phone Number	720-4530
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Central Index Key	0001840292
Amendment Flag	false
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common stock, $0.0001 par value per share
Trading Symbol	HLGN
Security Exchange Name	NYSE
Warrant
Document Information [Line Items]
Title of 12(b) Security	Warrants, each 35 warrants exercisable for one share of common stock at an exercise price of $402.50 per share
Trading Symbol	HLGN.W
Security Exchange Name	NYSE
Preferred Share Purchase Right
Document Information [Line Items]
Title of 12(b) Security	Preferred Share Purchase Rights
No Trading Symbol Flag	true
Security Exchange Name	NYSE

XML 8 hlg-20231107_htm.xml IDEA: XBRL DOCUMENT 0001840292 2023-11-07 2023-11-07 0001840292 us-gaap:CommonStockMember 2023-11-07 2023-11-07 0001840292 us-gaap:WarrantMember 2023-11-07 2023-11-07 0001840292 hlg:PreferredSharePurchaseRightMember 2023-11-07 2023-11-07 0001840292 false 8-K 2023-11-07 Heliogen, Inc. DE 001-40209 85-4204953 130 West Union Street Pasadena CA 91103 626 720-4530 false false false false Common stock, $0.0001 par value per share HLGN NYSE Warrants, each 35 warrants exercisable for one share of common stock at an exercise price of $402.50 per share HLGN.W NYSE Preferred Share Purchase Rights true NYSE true true EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 4 24 1 false 3 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://heliogen.com/role/Cover Cover Cover 1 false false All Reports Book All Reports hlg-20231107.htm hlg-20231107.xsd hlg-20231107_def.xml hlg-20231107_lab.xml hlg-20231107_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "hlg-20231107.htm": { "nsprefix": "hlg", "nsuri": "http://heliogen.com/20231107", "dts": { "inline": { "local": [ "hlg-20231107.htm" ] }, "schema": { "local": [ "hlg-20231107.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "hlg-20231107_def.xml" ] }, "labelLink": { "local": [ "hlg-20231107_lab.xml" ] }, "presentationLink": { "local": [ "hlg-20231107_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 1, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 4, "entityCount": 1, "segmentCount": 3, "elementCount": 32, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://heliogen.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hlg-20231107.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "hlg-20231107.htm", "first": true, "unique": true } } }, "tag": { "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant", "label": "Warrant [Member]" } } }, "auth_ref": [] }, "hlg_PreferredSharePurchaseRightMember": { "xbrltype": "domainItemType", "nsuri": "http://heliogen.com/20231107", "localname": "PreferredSharePurchaseRightMember", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Share Purchase Right", "label": "Preferred Share Purchase Right [Member]", "documentation": "Preferred Share Purchase Right" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "No Trading Symbol Flag", "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://heliogen.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001840292-23-000040-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001840292-23-000040-xbrl.zip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end